Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Simulating the Impact of Sugar-Sweetened Beverage Warning Labels in Three Cities.

Lee BY, Ferguson MC, Hertenstein DL, Adam A, Zenkov E, Wang PI, Wong MS, Gittelsohn J, Mui Y, Brown ST.

Am J Prev Med. 2018 Feb;54(2):197-204. doi: 10.1016/j.amepre.2017.11.003. Epub 2017 Dec 14.

PMID:
29249555
2.

Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.

DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST.

Vaccine. 2017 Jul 13;35(32):3974-3981. doi: 10.1016/j.vaccine.2017.05.093. Epub 2017 Jun 9.

PMID:
28606814
3.

How to determine if a model is right for neglected tropical disease decision making.

Lee BY, Bartsch SM.

PLoS Negl Trop Dis. 2017 Apr 20;11(4):e0005457. doi: 10.1371/journal.pntd.0005457. eCollection 2017 Apr.

4.

Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study.

DePasse JV, Smith KJ, Raviotta JM, Shim E, Nowalk MP, Zimmerman RK, Brown ST.

Am J Epidemiol. 2017 May 1;185(9):822-831. doi: 10.1093/aje/kww229.

5.

Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis.

Hodgson D, Baguelin M, van Leeuwen E, Panovska-Griffiths J, Ramsay M, Pebody R, Atkins KE.

Lancet Public Health. 2017 Feb;2(2):e74-e81. doi: 10.1016/S2468-2667(16)30044-5.

6.

A systems approach to obesity.

Lee BY, Bartsch SM, Mui Y, Haidari LA, Spiker ML, Gittelsohn J.

Nutr Rev. 2017 Jan;75(suppl 1):94-106. doi: 10.1093/nutrit/nuw049. Review.

7.

A systems approach to vaccine decision making.

Lee BY, Mueller LE, Tilchin CG.

Vaccine. 2017 Jan 20;35 Suppl 1:A36-A42. doi: 10.1016/j.vaccine.2016.11.033. Epub 2016 Dec 22.

8.

Agent-Based Modeling of Chronic Diseases: A Narrative Review and Future Research Directions.

Li Y, Lawley MA, Siscovick DS, Zhang D, Pagán JA.

Prev Chronic Dis. 2016 May 26;13:E69. doi: 10.5888/pcd13.150561. Review.

9.

Is population structure sufficient to generate area-level inequalities in influenza rates? An examination using agent-based models.

Kumar S, Piper K, Galloway DD, Hadler JL, Grefenstette JJ.

BMC Public Health. 2015 Sep 23;15:947. doi: 10.1186/s12889-015-2284-2.

10.

Enhancing dissemination and implementation research using systems science methods.

Burke JG, Lich KH, Neal JW, Meissner HI, Yonas M, Mabry PL.

Int J Behav Med. 2015 Jun;22(3):283-91. doi: 10.1007/s12529-014-9417-3.

11.

A simulation-based assessment of strategies to control Clostridium difficile transmission and infection.

Rubin MA, Jones M, Leecaster M, Khader K, Ray W, Huttner A, Huttner B, Toth D, Sablay T, Borotkanics RJ, Gerding DN, Samore MH.

PLoS One. 2013 Nov 21;8(11):e80671. doi: 10.1371/journal.pone.0080671. eCollection 2013.

12.

FRED (a Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using census-based populations.

Grefenstette JJ, Brown ST, Rosenfeld R, DePasse J, Stone NT, Cooley PC, Wheaton WD, Fyshe A, Galloway DD, Sriram A, Guclu H, Abraham T, Burke DS.

BMC Public Health. 2013 Oct 8;13:940. doi: 10.1186/1471-2458-13-940.

13.

Dynamic simulation of crime perpetration and reporting to examine community intervention strategies.

Yonas MA, Burke JG, Brown ST, Borrebach JD, Garland R, Burke DS, Grefenstette JJ.

Health Educ Behav. 2013 Oct;40(1 Suppl):87S-97S. doi: 10.1177/1090198113493090.

14.

A sequential experimental design method to evaluate a combination of school closure and vaccination policies to control an H1N1-like pandemic.

Luangkesorn KL, Ghiasabadi F, Chhatwal J.

J Public Health Manag Pract. 2013 Sep-Oct;19 Suppl 2:S37-41. doi: 10.1097/PHH.0b013e3182939a5c.

15.

Policies to reduce influenza in the workplace: impact assessments using an agent-based model.

Kumar S, Grefenstette JJ, Galloway D, Albert SM, Burke DS.

Am J Public Health. 2013 Aug;103(8):1406-11. doi: 10.2105/AJPH.2013.301269. Epub 2013 Jun 13.

16.

Removing the regional level from the Niger vaccine supply chain.

Assi TM, Brown ST, Kone S, Norman BA, Djibo A, Connor DL, Wateska AR, Rajgopal J, Slayton RB, Lee BY.

Vaccine. 2013 Jun 10;31(26):2828-34. doi: 10.1016/j.vaccine.2013.04.011. Epub 2013 Apr 17.

17.

Cost-effectiveness of pneumococcal and influenza vaccination standing order programs.

Lin CJ, Zimmerman RK, Smith KJ.

Am J Manag Care. 2013 Jan 1;19(1):e30-7.

18.

in silico surveillance: evaluating outbreak detection with simulation models.

Lewis B, Eubank S, Abrams AM, Kleinman K.

BMC Med Inform Decis Mak. 2013 Jan 23;13:12. doi: 10.1186/1472-6947-13-12.

19.

Employer-incurred health care costs and productivity losses associated with influenza.

Karve S, Misurski DA, Meier G, Davis KL.

Hum Vaccin Immunother. 2013 Apr;9(4):841-57. doi: 10.4161/hv.23413. Epub 2013 Jan 15.

20.

Risk-based input-output analysis of influenza epidemic consequences on interdependent workforce sectors.

Santos JR, May L, Haimar AE.

Risk Anal. 2013 Sep;33(9):1620-35. doi: 10.1111/risa.12002. Epub 2012 Dec 24.

Supplemental Content

Support Center